China Unveils Multiple Policies To Support Innovative Drugs Throughout Life Cycle

Removing Barriers Across R&D, Clinic, Payment

 
• By Xu Hu
  
China's policy measures to support innovative drugs development
China announces multiple new policy measures to better integrate and support R&D across the product life cycle. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Government Payers

More from China